JASPER THERAPEUTICS, INC. Cash
JASPER THERAPEUTICS, INC. (JSPR) had Cash of $700.00 thousand as of 2023-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2025-02-28
- 2023-12-31: Cash $700.00K.
- 2023-09-30: Cash $700.00K.
- 2023-06-30: Cash $700.00K.
- 2023-03-31: Cash $700.00K.
| Period end | Cash |
|---|---|
| 2023-12-31 | $700.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $700.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |